Table 1 
RESULTS OF IMMUNOTHERAPY IN PATIENTS 
WITH ADVANCED 
CANCER 
(3/90) 
Treatment with 
LAK/lL-2 
Cancer Diagnosis 
Evaluable+ 
( number 
CR 
of patients) 
PR 
CR + 
(%) 
Renal 
72 
8 
17 
35% 
Melanoma 
48 
4 
6 
21% 
I Colorectal 
1 
30 
1 
4 
17% 
i 
i Non Hodgkin's Lymphoma 
1 
7 
1 
3 
57% 
Sarcoma 
6 
0 
0 
- 
Lung 
5 
0 
0 
- 
1 Other-H- 
10 
0 
0 
— 
!i 
Total 178 
14 30 25% 
+ Includes all treated patients except one lost to follow-up and one died of 
therapy. 
++0ne patient each with cancer of breast, brain, esophagus, ovary, testes, 
thyroid, gastrinoma, unknown primary and two patients with Hodgkin’s 
lymphoma . 
I 
I 
( 
I 
1 
I 
Recombinant DNA Research, Volume 14 
[289] 
